RadNet (RDNT) 10-Q2021 Q1 Quarterly report

Filed: 10 May 21, 4:41pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: agent, aimed, Alternate, arrival, back, beneficial, catalog, consumption, country, exam, explicitly, floor, foreseeable, fully, moderate, mRNA, notification, onset, passed, ramp, repair, requisite, resurgence, safety, Shield, spurred, stimulate, study, sufficient, track, twelve, vaccine, written

Removed: adjustment, analytical, application, ascribed, Avenel, Barclay, behavior, Budapest, calculated, Call, Canada, Canadian, capitalizing, CECL, clarify, cloud, codification, Columbia, computing, conform, correct, counter, deferring, depend, depreciate, diluted, dollar, Edward, eliminate, employ, exclusively, expectation, experienced, extent, factored, flat, Forint, governmental, Hill, Hudson, Hungarian, Hungary, HVRA, identifiable, impacted, implementation, influence, initiated, Island, Lenox, local, lower, magnitude, membership, modified, mutually, nationwide, nonrecurring, Olney, past, planning, portfolio, Prince, procedural, procurement, prospective, prospectively, reaction, RECLASSIFICATION, reclassified, remitting, rent, repaid, research, resulted, retained, retrospective, retrospectively, revalued, salary, sell, September, shown, stability, subscription, sum, teleradiology, type, ultimately, unable, undiscounted, unintended, utilized, warrant, weak, Woodbridge

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated RDNT transcripts

RDNT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of RadNet, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on May 10, 2021 (the “Report”), I, Howard G. Berger, M.D., Chairman of the Board of Directors and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.


			/s/ Howard G. Berger, M.D.
			Howard G. Berger, M.D.
			Chairman, President and Chief Executive Officer
			(Principal Executive Officer)
			May 10, 2021

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.